Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Microbial ecology perturbation in human IgA deficiency.

Fadlallah J, El Kafsi H, Sterlin D, Juste C, Parizot C, Dorgham K, Autaa G, Gouas D, Almeida M, Lepage P, Pons N, Le Chatelier E, Levenez F, Kennedy S, Galleron N, de Barros JP, Malphettes M, Galicier L, Boutboul D, Mathian A, Miyara M, Oksenhendler E, Amoura Z, Doré J, Fieschi C, Ehrlich SD, Larsen M, Gorochov G.

Sci Transl Med. 2018 May 2;10(439). pii: eaan1217. doi: 10.1126/scitranslmed.aan1217.

PMID:
29720448
2.

Quality control of microbiota metagenomics by k-mer analysis.

Plaza Onate F, Batto JM, Juste C, Fadlallah J, Fougeroux C, Gouas D, Pons N, Kennedy S, Levenez F, Dore J, Ehrlich SD, Gorochov G, Larsen M.

BMC Genomics. 2015 Mar 14;16:183. doi: 10.1186/s12864-015-1406-7.

3.

Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.

Ortiz-Cuaran S, Villar S, Gouas D, Ferro G, Plymoth A, Khuhaprema T, Kalalak A, Sangrajrang S, Friesen MD, Groopman JD, Hainaut P.

Cancer Lett. 2013 Apr 30;331(1):46-51. doi: 10.1016/j.canlet.2012.11.012. Epub 2012 Nov 27.

PMID:
23200676
4.

TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.

Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, Groopman J, Chemin I, Hainaut P.

Carcinogenesis. 2012 Jun;33(6):1219-24. doi: 10.1093/carcin/bgs068.

5.

Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.

Villar S, Ortiz-Cuaran S, Abedi-Ardekani B, Gouas D, Nogueira da Costa A, Plymoth A, Khuhaprema T, Kalalak A, Sangrajrang S, Friesen MD, Groopman JD, Hainaut P.

PLoS One. 2012;7(6):e37707. doi: 10.1371/journal.pone.0037707. Epub 2012 Jun 4.

6.

Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.

Navas MC, Suarez I, Carreño A, Uribe D, Rios WA, Cortes-Mancera F, Martel G, Vieco B, Lozano D, Jimenez C, Gouas D, Osorio G, Hoyos S, Restrepo JC, Correa G, Jaramillo S, Lopez R, Bravo LE, Arbelaez MP, Scoazec JY, Abedi-Ardekani B, Santella RM, Chemin I, Hainaut P.

Hepat Res Treat. 2011;2011:582945. doi: 10.1155/2011/582945. Epub 2011 Oct 31.

7.

Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells.

Lereau M, Gouas D, Villar S, Besaratinia A, Hautefeuille A, Berthillon P, Martel-Planche G, Nogueira da Costa A, Ortiz-Cuaran S, Hantz O, Pfeifer GP, Hainaut P, Chemin I.

J Gen Virol. 2012 Mar;93(Pt 3):640-50. doi: 10.1099/vir.0.032482-0. Epub 2011 Nov 23.

PMID:
22113009
8.

TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations.

Abedi-Ardekani B, Gouas D, Villar S, Sotoudeh M, Hainaut P.

Hepat Res Treat. 2011;2011:475965. doi: 10.1155/2011/475965. Epub 2011 Aug 17.

9.

Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.

Villar S, Le Roux-Goglin E, Gouas DA, Plymoth A, Ferro G, Boniol M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P.

Environ Health Perspect. 2011 Nov;119(11):1635-40. doi: 10.1289/ehp.1103539. Epub 2011 Jul 18.

10.

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand.

Galy O, Chemin I, Le Roux E, Villar S, Le Calvez-Kelm F, Lereau M, Gouas D, Vieco B, Suarez I, Navas MC, Chevallier M, Norder H, Srivatanakul P, Karalak A, Sangrajrang S, Trépo C, Hainaut P.

Hepat Res Treat. 2011;2011:697162. doi: 10.1155/2011/697162. Epub 2011 Jun 30.

11.

Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.

Gouas DA, Shi H, Hautefeuille AH, Ortiz-Cuaran SL, Legros PC, Szymanska KJ, Galy O, Egevad LA, Abedi-Ardekani B, Wiman KG, Hantz O, Caron de Fromentel C, Chemin IA, Hainaut PL.

Carcinogenesis. 2010 Aug;31(8):1475-82. doi: 10.1093/carcin/bgq118. Epub 2010 Jun 10.

PMID:
20538734
12.

The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.

Gouas D, Shi H, Hainaut P.

Cancer Lett. 2009 Dec 1;286(1):29-37. doi: 10.1016/j.canlet.2009.02.057. Epub 2009 Apr 18. Review.

PMID:
19376640

Supplemental Content

Support Center